Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 21, 2019
Bioanalytical Systems announced Joe Flynn has been appointed as Chief Commercial Officer of the Company, effective as of February 21, 2019.
read more
Thursday, February 21, 2019
IQVIA has announced the appointment of Carol J. Burt to its board of directors, effective immediately.
read more
Thursday, February 21, 2019
Dr. Reddy’s announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone sublingual film, in the U.S. market.
read more
Thursday, February 21, 2019
MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology, has been acquired by ICON.
read more
Wednesday, February 20, 2019
QPharma has been engaged by several new clients in 2019, including a Top 15 pharmaceutical manufacturer, to provide a global KOL engagement and HCP targeting solution.
read more
Wednesday, February 20, 2019
Teva Pharmaceutical announced a settlement with the Federal Trade Commission (FTC) that will resolve all outstanding litigation between the parties.
read more
Wednesday, February 20, 2019
PPD and HLT of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market delivering data science-driven clinical trials.
read more
Wednesday, February 20, 2019
Empire Genomics announced the appointments of Andy Watson as CEO and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NY.
read more
Wednesday, February 20, 2019
Phillips-Medisize announced the groundbreaking of a new state of the art manufacturing facility located in the St. Croix Meadows development in Hudson, Wisconsin.
read more
Wednesday, February 20, 2019
LabCorp announced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE portfolio.
read more
Tuesday, February 19, 2019
ACG Group has expanded its footprint in Brazil with the opening of its new capsules manufacturing plant in Pouso Alegre-Minas Gerais.
read more
Tuesday, February 19, 2019
USP has announced an upcoming workshop in Maryland to address the challenges faced by industry, regulators, and other stakeholders regarding endotoxin and pyrogen testing.
read more
Tuesday, February 19, 2019
Catalent Pharma Solutions has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.
read more
Tuesday, February 19, 2019
Gliknik announced that it will receive a $15 million milestone payment from Pfizer following the start of a Phase I clinical trial of Pfizer drug candidate PF-06755347, previously known as GL-2045.
read more
Friday, February 15, 2019
The FDA has issued a final rule under section 503A of the FDCA, placing six bulk drug substances on the list of substances that compounders can use to compound drugs, known as the 503A bulks list.
read more